Pilot Study of the Buckeye Quit Stick for Tobacco Cessation in Patients with Diagnosed or Suspected Thoracic Cancer

What this Trial Is About

This research aims to evaluate a new tobacco cessation aid called the Buckeye Quit Stick for smokers diagnosed with or suspected of having thoracic cancer. Smoking remains the leading preventable cause of illness and death, and many cancer patients continue smoking despite diagnosis. The study focuses on addressing the habitual hand-to-mouth actions that challenge quitting, which the Buckeye Quit Stick is designed to simulate without using medications. Participants will receive the Buckeye Quit Stick along with a packet of smoking cessation information and a referral to a specialized smoking cessation clinic. The device aims to replace the physical habit of holding and smoking cigarettes, potentially reducing cravings and stress. The study will observe use and acceptance of this device among about 30 patients at Ohio State University thoracic clinics. Participants will be followed up at 2 weeks, 3 months, 6 months, and then up to 24 months after receiving the device. During these visits, researchers will collect information on recruitment, adherence, and retention rates, as well as gather feedback about the device and overall study experience. Surveys, interviews, and medical record reviews will support evaluating participant outcomes and satisfaction throughout the study period.

A Novel Tobacco Cessation Resource for Smokers With a Diagnosed or Suspected Thoracic Cancer